Literature DB >> 32869367

The New Normal in Clinical Trials: Decentralized Studies.

E Ray Dorsey1, Benzi Kluger1, Craig H Lipset2.   

Abstract

Mesh：

Year:  2020        PMID： 32869367     DOI： 10.1002/ana.25892

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  12 in total

1.  PD-ResNet for Classification of Parkinson's Disease From Gait.

Authors:  Xiaoli Yang; Qinyong Ye; Guofa Cai; Yingqing Wang; Guoen Cai
Journal:  IEEE J Transl Eng Health Med       Date:  2022-06-08

2.  What role can decentralized trial designs play to improve rare disease studies?

Authors:  J Moore; N Goodson; P Wicks; J Reites
Journal:  Orphanet J Rare Dis       Date:  2022-06-20       Impact factor: 4.303

3.  Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP).

Authors:  Ashish Sarraju; Clark Seninger; Vijaya Parameswaran; Christina Petlura; Tamara Bazouzi; Kiranbir Josan; Upinder Grewal; Thomas Viethen; Hardi Mundl; Joachim Luithle; Leonard Basobas; Alexis Touros; Michael J T Senior; Koen De Lombaert; Kenneth W Mahaffey; Mintu P Turakhia; Rajesh Dash
Journal:  NPJ Digit Med       Date:  2022-06-28

Review 4.  The impact of COVID-19 on the cell and gene therapies industry: disruptions, opportunities, and future prospects.

Authors:  Tingting Qiu; Yitong Wang; Shuyao Liang; Ru Han; Mondher Toumi
Journal:  Drug Discov Today       Date:  2021-04-20       Impact factor: 7.851

Review 5.  Reinforcing Collaboration and Harmonization to Unlock the Potentials of Advanced Therapy Medical Products: Future Efforts Are Awaited From Manufacturers and Decision-Makers.

Authors:  Tingting Qiu; Shuyao Liang; Yitong Wang; Claude Dussart; Borislav Borissov; Mondher Toumi
Journal:  Front Public Health       Date:  2021-11-25

6.  Recruitment for Remote Decentralized Studies in Parkinson's Disease.

Authors:  Taylor L Myers; Erika F Augustine; Elizabeth Baloga; Margaret Daeschler; Paul Cannon; Helen Rowbotham; Eli Chanoff; Stella Jensen-Roberts; Julia Soto; Robert G Holloway; Connie Marras; Caroline M Tanner; E Ray Dorsey; Ruth B Schneider
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

7.  Efficacy and Sustainability of Diabetes-Specific Meal Replacement on Obese and Overweight Type-2 Diabetes Mellitus Patients: Study Approaches for a Randomised Controlled Trial and Impact of COVID-19 on Trial Progress.

Authors:  Leong Chen Lew; Arimi Fitri Mat Ludin; Suzana Shahar; Zahara Abdul Manaf; Noorlaili Mohd Tohit
Journal:  Int J Environ Res Public Health       Date:  2022-04-01       Impact factor: 3.390

Review 8.  Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion.

Authors:  Noah Goodson; Paul Wicks; Jayne Morgan; Leen Hashem; Sinéad Callinan; John Reites
Journal:  NPJ Digit Med       Date:  2022-05-05

9.  How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis.

Authors:  Melanie Anderson
Journal:  Bioanalysis       Date:  2021-07-19       Impact factor: 2.681

Review 10.  Clinical Trial Considerations in Neuro-oncology.

Authors:  Eudocia Q Lee
Journal:  Curr Treat Options Oncol       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.